- Home
- PLX vs AOUT Comparison
PLX vs AOUT Comparison
Compare PLX & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- AOUT
- Stock Information
- Founded
- PLX 1993
- AOUT 2020
- Country
- PLX United States
- AOUT United States
- Employees
- PLX N/A
- AOUT N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- AOUT Ordnance And Accessories
- Sector
- PLX Health Care
- AOUT Industrials
- Exchange
- PLX Nasdaq
- AOUT Nasdaq
- Market Cap
- PLX 127.4M
- AOUT 123.8M
- IPO Year
- PLX 1998
- AOUT N/A
- Fundamental
- Price
- PLX $1.55
- AOUT $10.54
- Analyst Decision
- PLX Strong Buy
- AOUT Strong Buy
- Analyst Count
- PLX 1
- AOUT 2
- Target Price
- PLX $15.00
- AOUT $15.00
- AVG Volume (30 Days)
- PLX 571.5K
- AOUT 48.6K
- Earning Date
- PLX 08-14-2025
- AOUT 09-04-2025
- Dividend Yield
- PLX N/A
- AOUT N/A
- EPS Growth
- PLX N/A
- AOUT N/A
- EPS
- PLX 0.08
- AOUT N/A
- Revenue
- PLX $61,948,000.00
- AOUT $222,322,000.00
- Revenue This Year
- PLX $14.53
- AOUT N/A
- Revenue Next Year
- PLX $75.77
- AOUT $6.63
- P/E Ratio
- PLX $20.34
- AOUT N/A
- Revenue Growth
- PLX 62.79
- AOUT 10.55
- 52 Week Low
- PLX $0.89
- AOUT $8.14
- 52 Week High
- PLX $3.10
- AOUT $17.91
- Technical
- Relative Strength Index (RSI)
- PLX 47.97
- AOUT 66.08
- Support Level
- PLX $1.47
- AOUT $10.37
- Resistance Level
- PLX $1.57
- AOUT $10.61
- Average True Range (ATR)
- PLX 0.07
- AOUT 0.34
- MACD
- PLX -0.00
- AOUT 0.15
- Stochastic Oscillator
- PLX 31.82
- AOUT 100.00
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About AOUT American Outdoor Brands Inc.
American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.